OBJETO SONORO

We thank the University of Pennsylvania Human Immunology Core (funding under P30-CA016520) for primary monocytes and Valeria Reyes-Ruiz for assistance in their differentiation. We acknowledge funding from T32-AI-007324 (SMB), Bill and Melinda Gates Foundation Grand Challenges Explorations Award and R21-HD-074510 (JS), Defense Threat Reduction Agency, Project #18855636 (CC & JD), and Department of Defense Peer Reviewed Medical Research Program grant W81XWH-14-1-0204 (PB). Disclaimer: Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the U.S. Army.

Section 3.10 – Bibliography

1. 2014-2016 Ebola Outbreak in West Africa | Ebola Hemorrhagic Fever | CDC. Available at: https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/index.html. (Accessed: 6th March 2018)

2. Vetter, P. et al. Ebola Virus Shedding and Transmission: Review of Current Evidence. J. Infect. Dis.214, S177–S184 (2016).

3. Rowe, A. K. et al. Clinical, Virologic, and Immunologic Follow‐Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis179, S28–S35 (1999).

4. Uyeki, T. et al. Ebola Virus Persistence in Semen of Male Survivors. Clin Infect Dis62, 1552–1555 (2016).

5. Fischer, W. et al. Ebola Virus RNA Detection in Semen More than Two Years After Resolution of Acute Ebola Virus Infection. Open Forum Infect Dis ofx155- (0).

doi:10.1093/ofid/ofx155

6. Mate, S. E. et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N. Engl. J. Med.373, 2448–2454 (2015).

7. Blackley, D. J. et al. Reduced evolutionary rate in reemerged Ebola virus transmission chains. Sci. Adv.2, e1600378 (2016).

8. Thorson, A., Formenty, P., Lofthouse, C. & Broutet, N. Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open6, e008859 (2016).

9. Diallo, B. et al. Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clin Infect Dis63, 1353–1356 (2016).

10. Keita, M. et al. Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014–

11. Abbate, J., Murall, C., Richner, H. & Althaus, C. Potential Impact of Sexual Transmission on Ebola Virus Epidemiology: Sierra Leone as a Case Study. PLoS Negl. Trop D10,

e0004676 (2016).

12. Ryabchikova, E., Kolesnikova, L. & Luchko, S. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis179 Suppl 1, S199-202 (1999).

13. Wool-Lewis, R. J. & Bates, P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol.72, 3155–3160 (1998).

14. Wyers, M. et al. Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee. J. Infect. Dis.179 Suppl 1, S54-59 (1999).

15. Connolly, B. M. et al. Pathogenesis of experimental Ebola virus infection in guinea pigs.

J. Infect. Dis.179 Suppl 1, S203-217 (1999).

16. Geisbert, T. W. et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol.163, 2347–2370 (2003).

17. Bray, M. & Geisbert, T. W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol37, 1560–6 (2005).

18. Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol.70, 2208–2214 (1996).

19. Gupta, M., Mahanty, S., Ahmed, R. & Rollin, P. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF- alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology284, 20–5 (2001).

20. Alvarez, C. P. et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol76, 6841–4 (2002).

21. Simmons, G. et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology305, 115–23 (2003).

22. Matsuno, K. et al. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Bioph Res Co403, 144–148 (2010).

23. Powlesland, A. et al. A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Truncated Glycans. J Biol Chem283, 593–602 (2008).

24. Takada, A. et al. Human macrophage C-type lectin specific for galactose and N- acetylgalactosamine promotes filovirus entry. J Virol78, 2943–7 (2004).

25. Shimojima, M. et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol.80, 10109–10116 (2006).

26. Kondratowicz, A. S. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. U. S. A.

108, 8426–8431 (2011).

27. Mulherkar, N., Raaben, M., Torre, J., Whelan, S. & Chandran, K. The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway.

Virology419, 72–83 (2011).

28. Nanbo, A. et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog.6, e1001121 (2010).

29. Saeed, M., Kolokoltsov, A., Albrecht, T. & Davey, R. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog6, e1001110 (2010).

30. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science308, 1643–1645 (2005).

31. Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature477, 340–343 (2011).

32. Côté, M. et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature477, 344–8 (2011).

33. Spence, J. S., Krause, T. B., Mittler, E., Jangra, R. K. & Chandran, K. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. mBio7, e01857-01815 (2016). 34. Castellano, L. M. & Shorter, J. The Surprising Role of Amyloid Fibrils in HIV Infection.

Biology1, 58–80 (2012).

35. Münch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell131, 1059–1071 (2007).

36. Arnold, F. et al. Naturally Occurring Fragments from Two Distinct Regions of the Prostatic Acid Phosphatase Form Amyloidogenic Enhancers of HIV Infection. J Virol86, 1244–1249 (2012).

37. Roan, N. R. et al. Peptides Released by Physiological Cleavage of Semen Coagulum Proteins Form Amyloids that Enhance HIV Infection. Cell Host Microbe10, 541–550 (2011). 38. Roan, N. R. et al. The cationic properties of SEVI underlie its ability to enhance human

immunodeficiency virus infection. J. Virol.83, 73–80 (2009).

39. Lump, E. et al. A molecular tweezer antagonizes seminal amyloids and HIV infection.

eLife4, (2015).

40. Münch, J. et al. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology10, 148 (2013).

41. Tang, Q., Roan, N. R. & Yamamura, Y. Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture. J. Virol.87, 12583–12591 (2013).

42. Torres, L., Ortiz, T. & Tang, Q. Enhancement of herpes simplex virus (HSV) infection by seminal plasma and semen amyloids implicates a new target for the prevention of HSV infection. Viruses7, 2057–2073 (2015).

43. Jones, S. M. et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med.11, 786–790 (2005).

44. Haines, K., Burgt, N., Francica, J., Kaletsky, R. & Bates, P. Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for

45. Jahrling, P. B. et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J. Infect. Dis.179 Suppl 1, S224-234 (1999).

46. Wilson, J. A. et al. Epitopes involved in antibody-mediated protection from Ebola virus.

Science287, 1664–1666 (2000).

47. Wec, A. Z. et al. A ‘Trojan horse’ bispecific-antibody strategy for broad protection against

ebolaviruses. Science354, 350–354 (2016).

48. Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A.92, 7297–7301 (1995). 49. Johansen, L. et al. FDA-approved selective estrogen receptor modulators inhibit Ebola

virus infection. Sci Transl Med.5, 190ra79 (2013).

50. Hierholzer, J. C. & Killington, R. A. Virus isolation and quantitation. in Virology methods manual 25–46 (Elsevier, 1996).

51. Takada, A. et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci94, 14764–14769 (1997).

52. Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature454, 177–182 (2008).

53. Noda, T. et al. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol.76, 4855–4865 (2002).

54. Kallstrom, G. et al. Analysis of Ebola virus and VLP release using an immunocapture assay. J. Virol. Methods127, 1–9 (2005).

55. Shoemaker, C. J. et al. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PloS One8, e56265 (2013).

56. Moller-Tank, S. & Maury, W. Ebola virus entry: a curious and complex series of events.

PLoS Pathog.11, e1004731 (2015).

57. Owen, D. & Katz, D. A Review of the Physical and Chemical Properties of Human Semen and the Formulation of a Semen Simulant. J Androl26, 459–469 (2005).

58. Serpell, L. C., Berriman, J., Jakes, R., Goedert, M. & Crowther, R. A. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc. Natl. Acad. Sci. U. S. A.97, 4897–4902 (2000).

59. Cooper, T. K. et al. Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model. Sci. Rep.8, 1250 (2018).

60. Robinson, C. M., Jesudhasan, P. R. & Pfeiffer, J. K. Bacterial Lipopolysaccharide Binding Enhances Virion Stability and Promotes Environmental Fitness of an Enteric Virus. Cell Host Microbe15, 36–46 (2014).

61. Roan, N. R. et al. Semen amyloids participate in spermatozoa selection and clearance.